Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 527,370 | 579,112 | 370,600 | 285,000 | 1,128,967 | 2,891,049 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 527,370 | 579,112 | 370,600 | 285,000 | 1,128,967 | 2,891,049 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 1,157,400 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 1,733,649 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 527,370 | 579,112 | 370,600 | 285,000 | 1,128,967 | 2,891,049 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 581 | 421 | 420 | 145 | 5,365 | 6,932 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | 2,897,981 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2021 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2021 |
(iii) Distributable Amount for 2021 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2021 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2021 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2021: | ||||
| a From 2016....... | ||||
| b From 2017....... | ||||
| c From 2018....... | ||||
| d From 2019....... | ||||
| e From 2020....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2021 distributable amount | ||||
|
i
Carryover from 2016 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2021 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2021 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2021, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2021. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2022. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2017..... | ||||
| b Excess from 2018..... | ||||
| c Excess from 2019..... | ||||
| d Excess from 2020..... | ||||
| e Excess from 2021..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | MARTIN AND ANN MURPHY ARE HUSBAND AND WIFE AND BOTH SERVE AS DIRECTORS ON THE BOARD. |
| FORM 990, PART VI, SECTION A, LINE 6 | THE SOCIETY IS COMPRISED OF MEMBERS. THE PRIMARY QUALIFICATION FOR MEMBERSHIP IS TO BE AN ONCOLOGIST OR OTHERWISE PROFESSIONALLY INVOLVED WITH ONCOLOGY. |
| FORM 990, PART VI, SECTION B, LINE 11B | STO BOARD OF DIRECTORS FORM 990 REVIEW PROCESS: THE COMPLETED IRS FORM 990 IS REVIEWED BY THE CHAIRMAN AND TREASURER OF THE STO BOARD OF DIRECTORS. AFTER THIS REVIEW, PROPOSED CHANGES ARE DISCUSSED WITH OUR TAX ACCOUNTANT. IF NO CHANGES ARE NECESSARY, COPIES OF THE 990 ARE SHARED WITH THE FULL BOARD AND VOTED UPON PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE PURPOSE OF THE CONFLICT OF INTEREST POLICY IS TO PROTECT THE SOCIETY FOR TRANSLATIONAL ONCOLOGY, INC. ("STO") AND ITS INTERESTS WHEN IT IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF AN OFFICER, MEMBER OF THE BOARD OF DIRECTORS ("DIRECTOR"), OR MIGHT RESULT IN A POSSIBLE EXCESS BENEFIT TRANSACTION. THIS POLICY IS INTENDED TO SUPPLEMENT, BUT NOT REPLACE ANY APPLICABLE STATE AND FEDERAL LAWS GOVERNING CONFLICT OF INTEREST APPLICABLE TO NON-PROFIT AND CHARITABLE ORGANIZATIONS AND PROVISIONS IN STO'S BYLAWS. 1. DUTY TO DISCLOSE IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS OR OTHERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. 2. DETERMINING WHETHER A CONFLICT OF INTEREST EXISTS AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. 3. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST A. AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE GOVERNING BOARD OR COMMITTEE MEETING, BUT AFTER THE PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. B. THE CHAIRPERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. C. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER STO CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. D. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE IF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN STO'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION IT SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. ADDITIONALLY, ALL STO BOARD MEMBERS MUST ABIDE BY THE SAME PEER-REVIEW SYSTEM AS DO THE SENIOR EDITORS, BY RECUSING THEMSELVES FROM PROCEEDINGS AS APPROPRIATE. CME PROGRAM - BALANCE AND INDEPENDENCE POLICY: A. THE CME COMMITTEE, IN CONJUNCTION WITH THE EDITORIAL BOARD, PROVIDES EXPERTISE IN SELECTING AND REVIEWING MATERIALS FOR 'THE ONCOLOGIST' CME ONLINE AND FOR QUALITY ASSURANCE AND CONTINUING REVIEW OF THE ONLINE EDUCATIONAL MATERIALS. B. THE ACCREDITED PROVIDER MAINTAINS EXCLUSIVE CONTROL OVER THE PLANNING AND CONTENT OF THE ARTICLES THAT APPEAR IN 'THE ONCOLOGIST AND ENSURES COMPLIANCE WITH ALL ACCME AND AMA REQUIREMENTS. C. THE CME COMMITTEE AND ANY EDUCATIONAL PARTNERS SHARE A CONCERN TO SAFEGUARD THE INTEGRITY OF 'THE ONCOLOGIST' CME ONLINE PROGRAM. TO THAT END, THEY TAKE JOINT RESPONSIBILITY FOR ENSURING THAT: 1. ANY POTENTIAL CONFLICTS OF INTEREST ARE RESOLVED VIA THE ONCOLOGIST'S ANONYMOUNS PEER REVIEW PROCESS. EDITORS' DISCLOSURES ARE PUBLISHED ANNUALLY ONLINE, WHEREAS REVIEWERS' DISCLOSURES ARE HELD IN CONFIDENCE WITHIN THE EDITORIAL OFFICE. 2. ALL MANUSCRIPTS ARE REVIEWED BY THE EDITORIAL BOARD WITH AD HOC ASSISTANCE FROM TWO OR MORE EXTERNAL EXPERTS IN THE FIELD. ALL FINAL PUBLICATION DECISIONS ARE MADE BY THE EDITORIAL BOARD. THE ACCEPTANCE OF A MANUSCRIPT IS BASED ON ITS ORIGINALITY AND IMPORTANCE TO THE FIELD AS ASSESSED BY THE EDITORS. FOR MORE INFORMATION ABOUT THE SUBMISSION AND PEER REVIEW PROCESS, VISIT HTTP://AUTHORS.THEONCOLOGIST.COM. 3. ALL INFORMATION IS SUBMITTED AND REVIEWED AND FOUND TO BE SCIENTIFICALLY RIGOROUS, BASED ON THE BEST AVAILABLE EVIDENCE, FAIR AND BALANCED, AND FREE OF COMMERCIAL BIAS. ALL OF THE RECOMMENDATIONS INVOLVING CLINICAL MEDICINE IN THE CME ACTIVITIES ARE BASED ON EVIDENCE THAT IS ACCEPTED WITHIN THE PROFESSION OF MEDICINE AS ADEQUATE JUSTIFICATION FOR THEIR INDICATIONS AND CONTRA-INDICATIONS IN THE CARE OF PATIENTS. ALL SCIENTIFIC RESEARCH REFERRED TO, REPORTED OR USED IN A CME COURSE IN SUPPORT OR JUSTIFICATION OF A PATIENT CARE RECOMMENDATION CONFORMS TO THE GENERALLY ACCEPTED STANDARDS OF EXPERIMENTAL DESIGN, DATA COLLECTION AND ANALYSIS. D. THE STANDARDS OF COMMERCIAL SUPPORT ALSO REQUIRE THAT PRESENTATIONS GIVE A BALANCED VIEW OF THERAPEUTIC OPTIONS. USE OF GENERIC NAMES WILL CONTRIBUTE TO THIS IMPARTIALITY. WHEN IT IS NECESSARY TO USE A TRADE NAME, THEN THOSE OF SEVERAL COMPANIES ARE USED, NOT JUST TRADE NAMES FROM A SINGLE COMPANY. E. IN COMPLIANCE WITH THE STANDARDS OF THE ACCREDITATION COUNCIL FOR CME, IT IS THE POLICY OF THE CME COMMITTEE TO ENSURE BALANCE, INDEPENDENCE, OBJECTIVITY, AND SCIENTIFIC RIGOR IN ALL OF ITS EDUCATIONAL ACTIVITIES AND TO INCLUDE INFORMATION FREE OF COMMERCIAL BIAS AND BASED ON THE BEST EVIDENCE AVAILABLE. ALL INDIVIDUALS IN A POSITION TO INFLUENCE THE CONTENT OF AN ACTIVITY HAVE DISCLOSED RELEVANT FINANCIAL INTERESTS OR RELATIONSHIPS OF THEIR OWN, THEIR SPOUSE/PARTNER, OR THEIR WORKSITE, WITH MANUFACTURERS OR PROVIDERS OF COMMERCIAL PRODUCTS, SERVICES, TECHNOLOGY, OR PROGRAMS; AND DISCLOSED RELATIONSHIPS WITH CURRENT NON-GOVERNMENTAL SUPPORTERS OF THE ACTIVITIES. THE FACULTY AND PLANNERS HAVE INDICATED THAT THEY HAVE NO RELEVANT COMMERCIAL RELATIONSHIPS. FOR A LIST OF THE FACULTY AND PLANNERS, PLEASE VISIT THE EDITORIAL BOARD ONLINE AT HTTP://THEONCOLOGIST.ALPHAMEDPRESS.ORG/SITE/MISC/TO_EDBOARD.PDF F. NO PUSH CME - THE JOURNAL'S CME ACTIVITIES ARE AVAILABLE ONLY TO CLINICIANS WHO ARE ACTIVE SUBSCRIBERS TO 'THE ONCOLOGIST' PRINT AND ONLINE. G. COURTESY CONTENT REVIEWS - 'THE ONCOLOGIST AND THE SOCIETY FOR TRANSLATIONAL ONCOLOGY ARE SOLELY RESPONSIBLE FOR THE CONTROL OF THE CONTENT, BOTH CME AND NON-CME, CONTAINED IN THE JOURNAL. AS SUCH, COURTESY CONTENT REVIEWS FROM COMMERCIAL INTERESTS AND OTHER GRANTOR TYPES ARE STRICTLY PROHIBITED. CONTENT, BOTH CME AND NON-CME, CONTAINED IN THE JOURNAL. AS SUCH, COURTESY CONTENT REVIEWS FROM COMMERCIAL INTERESTS AND OTHER GRANTOR TYPES ARE STRICTLY PROHIBITED. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE SOCIETY CURRENTLY MAKES ITS IRS FORM 990, ORGANIZATIONAL DOCUMENTS, AND CONFLICT OF INTEREST POLICY AVAILABLE FOR PUBLIC INSPECTION ON AN AS REQUESTED BASIS. THESE REQUESTS CAN BE MADE VIA EMAIL TO ADMIN@STO-ONLINE.ORG OR VIA MAIL OR FAX SENT TO ITS DURHAM, NC OFFICE. |
| FORM 990, PART IX, LINE 11G | PAYROLL PROCESSING FEES: PROGRAM SERVICE EXPENSES 508. MANAGEMENT AND GENERAL EXPENSES 127. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 635. CONTRACTED SERVICES: PROGRAM SERVICE EXPENSES 154,013. MANAGEMENT AND GENERAL EXPENSES 37,503. FUNDRAISING EXPENSES 1,000. TOTAL EXPENSES 192,516. PROGRAM CONSULTANTS/CONTRACTORS: PROGRAM SERVICE EXPENSES 79,360. MANAGEMENT AND GENERAL EXPENSES 19,840. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 99,200. |
| Software ID: | |
| Software Version: |